Cencora Inc. ($COR) Stock Forecast: Up 5.1% Today

What is Cencora Inc.?

Cencora (NYSE: COR) is a high-performing stock with a market capitalization of $56.22 billion.

Why is Cencora Inc. going up?

COR stock is up 5.1% on Sep 23, 2025 16:40

• The strong bullish movement in Cencora (NYSE: COR) today may be linked to its impressive long-term outperformance of the market, boasting an average annual return of 20.51% over the past decade.
• Investors seem to be drawn to COR because of its consistent growth and its ability to produce returns that surpass the market average significantly.
• The coverage of COR's exceptional performance in recent times could have further piqued investor interest, leading to an increase in the stock price.

COR Price Chart

COR Technical Analysis

COR News

$1000 Invested In Cencora 10 Years Ago Would Be Worth This Much Today - Cencora ( NYSE:COR )

Cencora COR has outperformed the market over the past 10 years by 7.48% on an annualized basis producing an average annual return of 20.51%. Currently, Cencora has a market capitalization of $56.22 billion.

https://www.benzinga.com/insights/news/25/09/47705821/1000-invested-in-cencora-10-years-ago-would-be-worth-this-much-today

Trending Today

FuelCell Energy ($FCEL) Stock Forecast: Down 5.8% Today

Affirm Holdings Inc. ($AFRM) Stock Forecast: Down 5.1% Today

Reddit Inc ($RDDT) Stock Forecast: Down 7.4% Today

Chegg Inc. ($CHGG) Stock Forecast: Down 7.0% Today

Shopify Inc. Class A Subordinate ($SHOP) Stock Forecast: Down 5.2% Today

Enphase Energy Inc. ($ENPH) Stock Forecast: Down 5.1% Today

Hewlett Packard Enterprise Company ($HPE) Stock Forecast: Down 1.1% Today

Citigroup Inc. ($C) Stock Forecast: Down 0.1% Today

S&P 500 Index ($SPX) Index Forecast: Down 0.6% Today

Rivian Automotive Inc. ($RIVN) Stock Forecast: Up 5.3% Today

Cencora Inc. Price History

06.10.2024 - COR Stock was up 5.1%

• In the fourth quarter of 2024, COR exceeded sales expectations, seeing a significant revenue increase in both U.S. and International Healthcare Solutions segments.
• Despite a year-over-year decline in margins, COR's overall Q4 performance was impressive, resulting in an increased dividend and positive market sentiment.
• Analysts were optimistic about COR's earnings and revenue estimates, suggesting potential for ongoing stock growth.
• The market responded positively to COR's better-than-expected Q4 earnings and revenue, propelling the bullish movement in the stock price.

03.00.2025 - COR Stock was up 3.4%

• Market expectations point towards a potential increase in COR stock, reflecting optimistic investor sentiment.
• COR has outperformed the market by 4.82% annually over the last decade, highlighting its robust historical performance.
• Today's positive uptick in COR may be linked to the favorable outlook in the options market and its consistent market outperformance.

15.09.2024 - COR Stock was up 2.3%

• COR experienced a strong bullish movement recently, possibly due to investor optimism and confidence in the company's financial performance.
• Expectations of COR surpassing earnings estimates in the near future may have influenced the positive market sentiment.
• The consistent outperformance of COR compared to the market could have attracted more investors, boosting the stock price.
• In summary, COR's solid historical performance, anticipated positive earnings, and market outperformance likely drove the recent bullish movement in the stock.

08.04.2025 - COR Stock was down 4.2%

• Despite surpassing Q2 earnings and revenue estimates, COR witnessed a bearish movement in the market.
• Concerns about revenue sustainability and competition in the pharmaceutical sector may have contributed to the market's negative reaction.
• Investor caution regarding the company's growth sustainability could result in profit-taking and a bearish stock price trend.
• Broader economic factors and sector-specific challenges in the pharmaceutical industry might also influence the market movement.

08.04.2025 - COR Stock was down 5.2%

• Despite surpassing Q2 earnings and revenue expectations, COR observed a decline in its stock price today.
• The high demand for weight loss drugs and specialty products might not have sustained the stock's elevated value, resulting in profit-taking by traders.
• The market's response could be due to concerns regarding future growth prospects or uncertainties about the company's trajectory.
• Investors may have anticipated stronger results or guidance from COR, triggering a stock sell-off despite its recent accomplishments in the healthcare solutions industry.

15.08.2025 - COR Stock was down 1.9%

• The factors behind the bearish movement in COR include:
• Investors taking profits following a recent uptrend.
• Worries about decreased demand for cloud computing services.
• Negative impact of overall market sentiment on tech stocks.
• Absence of specific positive news or catalysts to drive buying activity for COR.

05.01.2025 - COR Stock was down 0.3%

• The bearish movement in COR stock today could be attributed to profit-taking by investors despite the company surpassing Q1 earnings and revenue estimates.
• The strong performance in the U.S. Healthcare Solutions segment might have been already priced in, leading to a sell-off.
• The stiff competition could be causing concerns among investors, leading to the bearish trend.
• The stock's historical outperformance and market capitalization may have set high expectations, and any deviation from this trajectory could trigger a negative market reaction.

07.04.2025 - COR Stock was up 5.7%

• COR outperformed Q2 earnings and revenue expectations, signaling robust financial results.
• The U.S. Healthcare Solutions segment's favorable outlook is anticipated to be a key driver of COR's success.
• Analysts hold a positive view on COR's crucial metrics for the quarter, indicating a favorable path for the company.
• Investors reacted favorably to the strong performance and growth potential of COR, leading to the uptrend in the stock price.

06.07.2025 - COR Stock was down 6.4%

• The bearish movement in COR stock today may be linked to the market's reaction to the company's Q3 earnings, despite exceeding earnings and revenue expectations. Here's a breakdown of the situation:
• The market could have anticipated more robust results given COR's consistent outperformance, leading to a sell-off.
• Worries about international challenges impacting Q3 figures might have unsettled investors, overshadowing the positive earnings beats.
• Investors expecting a significant earnings beat based on Wall Street projections might have felt let down, resulting in a decline in the stock's value.
• While hopes were high for COR's earnings growth, the market's response today indicates that even surpassing estimates does not always guarantee a positive reaction from investors.

04.03.2025 - COR Stock was down 0.7%

• Despite being considered a safe bet during market volatility, COR faced a strong bearish movement today.
• The comparison with other medical stocks like Intensity Therapeutics Inc. may have highlighted weaknesses in COR's performance, contributing to the bearish trend.
• The overall market volatility, potentially influenced by external factors, could have also played a role in the bearish movement of COR today.

23.08.2025 - COR Stock was up 5.1%

• The strong bullish movement in Cencora (NYSE: COR) today may be linked to its impressive long-term outperformance of the market, boasting an average annual return of 20.51% over the past decade.
• Investors seem to be drawn to COR because of its consistent growth and its ability to produce returns that surpass the market average significantly.
• The coverage of COR's exceptional performance in recent times could have further piqued investor interest, leading to an increase in the stock price.

31.06.2025 - COR Stock was down 2.4%

• The decline in COR's stock today could be due to profit-taking by investors who were possibly anticipating a positive earnings outcome.
• Comparisons with McKesson (MCK) in the medical sector may have impacted investor sentiment, resulting in a sell-off of COR as it might have shown lower performance compared to its sector so far this year.
• Investors might be reassessing their holdings in COR based on its performance relative to McKesson, potentially influencing the downward trend in the stock.